Dr. Michel Sadelain, ACGT Research Fellow, discusses the progress made in T cell therapy. This novel treatment research was originally funded by ACGT.
Dr. Michel Sadelain, ACGT Research Fellow, discusses the progress made in T cell therapy. This novel treatment research was originally funded by ACGT.
Learn more about exciting progress in targeted cancer therapies